Stock Quote
Inovio Biomedical Corporation (INO) (American Stock Exchange)
$1.57
23 Nov 2009
+2.61%
$1.53
$1.66
2,606,500
$1.68
$1.50
$3.40
$0.17
2.87
1,306,970
INO
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Dhillon, Avtar | Chairman of the Board | 668,692 |
| Kim, J. Joseph | President, Chief Executive Officer, Director | -- |
| Kies, Peter | Chief Financial Officer | 319,715 |
Profile
Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. Inovio develops deoxyribonucleic acid (DNA) delivery solutions based on electroporation, which uses brief, controlled... Full Description
Company Address
Inovio Biomedical Corporation
11494 Sorrento Valley Road
San Diego CA 92121
P: +1858.5976006
F: +1858.5970119
11494 Sorrento Valley Road
San Diego CA 92121
P: +1858.5976006
F: +1858.5970119
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Intuitive Surgical, Inc. | $280.80 | +4.36 |
| IRIDEX Corporation | $3.00 | +0.20 |
| Insight Health Services Corp. | $0.24 | -0.01 |
| INO | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 23.46 | 29.90 |
| ROI(TTM) | -43.69 | 2.35 |
| ROE(TTM) | -46.63 | 3.59 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -0.34 |
| Total Revenue | $3.65M |
| Net Income | $-2.96M |
| EPS | $-0.03 |
